Published in Thromb Res on January 01, 2011
Antiplatelet resistance and thromboembolic complications in neurointerventional procedures. Front Neurol (2011) 1.01
Pharmacogenomics: application to the management of cardiovascular disease. Clin Pharmacol Ther (2011) 0.89
Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content. Pharmacogenomics J (2015) 0.85
Regulatory polymorphisms in CYP2C19 affecting hepatic expression. Drug Metabol Drug Interact (2013) 0.78
Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis. Eur J Clin Pharmacol (2014) 0.78
Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese. BMC Med Genet (2014) 0.77
CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease. Indian Heart J (2013) 0.76
Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines. Ann Lab Med (2017) 0.75
Development of a multiplex and cost-effective genotype test toward more personalized medicine for the antiplatelet drug clopidogrel. Int J Mol Sci (2014) 0.75
Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Circ Res (2007) 1.70
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J Am Coll Cardiol (2013) 1.65
Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study. Circ Cardiovasc Interv (2010) 1.60
A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation. Cardiology (2012) 1.50
Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study. Eur Heart J (2012) 1.47
Risk stratification using computed tomography coronary angiography in patients undergoing intermediate-risk noncardiac surgery. J Am Coll Cardiol (2013) 1.45
Prognostic value of brachial-ankle pulse wave velocity in patients with non-ST-elevation myocardial infarction. Coron Artery Dis (2017) 1.39
Extracellular matrix changes in stented human coronary arteries. Circulation (2004) 1.32
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis. Ann Intern Med (2013) 1.24
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype. JACC Cardiovasc Interv (2011) 1.10
PRASFIT-ACS: important evidence against a "one-guideline-fits-all-races" approach to antiplatelet therapy. Circ J (2014) 1.09
Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter (2009) 1.09
Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin. Circ Cardiovasc Interv (2011) 1.07
Outcome of significant functional tricuspid regurgitation after percutaneous mitral valvuloplasty. Am Heart J (2003) 1.03
Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents. Heart (2011) 1.00
Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel. Am J Cardiol (2012) 0.98
Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients. Korean J Intern Med (2007) 0.97
Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis. Atherosclerosis (2004) 0.95
Clopidogrel with aspirin in minor stroke or transient ischemic attack. N Engl J Med (2013) 0.93
VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. Cancer Sci (2012) 0.91
Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clin Res Cardiol (2012) 0.90
Gender differences among korean patients with coronary spasm. Korean Circ J (2009) 0.90
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study. JACC Cardiovasc Interv (2010) 0.89
Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages. J Nutr (2011) 0.89
Clinical manifestations of arrhythmogenic right ventricular cardiomyopathy in Korean patients. Int J Cardiol (2007) 0.89
Prognosis and natural history of drug-related bradycardia. Korean Circ J (2009) 0.88
Cyclosporine A treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: a case with long-term follow-up. Korean J Hematol (2012) 0.88
Clinical features and gene analysis in Korean patients with early-onset Parkinson disease. Arch Neurol (2006) 0.88
Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. J Cell Biochem (2012) 0.87
Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer. Ann Lab Med (2013) 0.87
The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study. Korean J Intern Med (2010) 0.87
Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome. Circ J (2006) 0.87
Long-term outcome of simultaneous kissing stenting technique with sirolimus-eluting stent for large bifurcation coronary lesions. Catheter Cardiovasc Interv (2007) 0.87
Implantable cardioverter-defibrillator implantation in a patient with atrial standstill. Yonsei Med J (2009) 0.86
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies. Am Heart J (2011) 0.86
Cangrelor: an emerging therapeutic option for patients with coronary artery disease. Curr Med Res Opin (2014) 0.85
Novel SGCE gene mutation in a Korean patient with myoclonus-dystonia with unique phenotype mimicking Moya-Moya disease. Mov Disord (2007) 0.85
The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay. Eur Heart J (2008) 0.85
Transient right ventricular dysfunction after pericardiectomy in patients with constrictive pericarditis. Korean Circ J (2011) 0.85
Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression in patients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque. Atherosclerosis (2006) 0.84
Delayed ventricular septal rupture following blunt chest trauma. Korean Circ J (2011) 0.84
Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant (2005) 0.84
Central aortic stiffness and its association with ascending aorta dilation in subjects with a bicuspid aortic valve. J Am Soc Echocardiogr (2011) 0.84
A case of spontaneous coronary artery dissection healed by medical treatment: serial findings of coronary angiography, intravascular ultrasound and multi-detector computed tomography. Korean Circ J (2011) 0.84
Astragalin inhibits airway eotaxin-1 induction and epithelial apoptosis through modulating oxidative stress-responsive MAPK signaling. BMC Pulm Med (2014) 0.84
Nrf2 regulates curcumin-induced aldose reductase expression indirectly via nuclear factor-kappaB. Pharmacol Res (2008) 0.83
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy. Lung Cancer (2012) 0.82
Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y12 assay. J Thromb Thrombolysis (2010) 0.82
Defining predictive values using three different platelet function tests for CYP2C19 phenotype status on maintenance dual antiplatelet therapy after PCI. Platelets (2013) 0.82
Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis. Biomed Res Int (2013) 0.82